Updates from ASCO’s 2019 Annual Meeting
Monday, July 15, 2019
Each year , the American Society of Clinical Oncology (ASCO) brings together thousands of cancer experts to present and learn about recent breakthroughs in cancer research.
In this webinar, speaker Debu Tripathy, MD, covers findings from MONALEESA-7, which showed premenopausal women who take a CDK 4/6 inhibitor as part of treatment for metastatic hormone receptor-positive breast cancer live longer than those who take hormonal therapy alone. He also discusses findings for people with all stages of disease and for those with HER2-positive and triple-negative breast cancer.